Crinetics Pharmaceuticals, Inc. (CRNX) Financials

CRNX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.4 billion 120.7 million
Dec. 31, 2025 1.1 billion 143.4 million
Sept. 30, 2025 1.2 billion 123.9 million
June 30, 2025 1.3 billion 118.0 million

CRNX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -125.5 million 29.7 million
Dec. 31, 2025 -93.4 million 21.7 million
Sept. 30, 2025 -111.6 million 22.7 million
June 30, 2025 -89.1 million 26.1 million

CRNX Net Income

No data available :(

CRNX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.3 billion - 41.3 million
Dec. 31, 2025 1.0 billion - 42.1 million
Sept. 30, 2025 1.1 billion - 49.1 million
June 30, 2025 1.2 billion - 49.9 million

CRNX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 104.1 million
Dec. 31, 2025 94.1 million
Sept. 30, 2025 94.2 million
June 30, 2025 93.8 million

CRNX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 820000 100.1 million 50.8 million -
Dec. 31, 2025 458000 85.1 million 53.7 million -
Sept. 30, 2025 863000 90.5 million 52.3 million -
June 30, 2025 3.2 million 80.3 million 49.8 million -

CRNX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 10.7 million 200000
Dec. 31, 2025 6.2 million -459000
Sept. 30, 2025 143000 90.5 million
June 30, 2025 1.0 million 959000

CRNX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CRNX

Price: $35.12

52 week price:
25.83
57.99

Earnings Per Share: -5.14 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 265100

Market Capitalization: 3.5 billion

Links: